Laboratory Publications
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study - Archive ouverte HAL
Article Dans Une Revue Leukemia & lymphoma Année : 2021

Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study

Fichier non déposé

Dates et versions

hal-04907601 , version 1 (23-01-2025)

Identifiants

Citer

Guillaume Aussedat, Delphine Maucort-Boulch, Philippe Rey, Violaine Safar, Lionel Karlin, et al.. Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study. Leukemia & lymphoma, 2021, 63 (3), pp.599-607. ⟨10.1080/10428194.2021.1998483⟩. ⟨hal-04907601⟩
59 Consultations
0 Téléchargements

Altmetric

Partager

  • More